Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines

Patent 7709502 was granted and assigned to Celgene on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12065423 Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits on 30 Oct, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2023
Edits made to:
Article (+214 characters)
Article

Patent abstract

Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNFα in a mammal.

Edits on 18 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 18 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David I. Stirling0
George W. Muller0
Roger Shen-Chu Chen0
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=077095020
Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines

Infobox
Patent Number
077095020
Patent Number
77095020
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Celgene
Celgene
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
077095020
Date of Patent
May 4, 2010
0
Patent Application Number
114018580
Date Filed
April 12, 2006
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=077095020
Patent Primary Examiner
‌
Celia Chang
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07709502
Edits on 4 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 4 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines

Infobox
Is a
Patent
Patent
Current assignee
Celgene
Celgene
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07709502
Date of patent
May 4, 2010
Patent application number
11401858
Date Filed
April 12, 2006
Patent primary examiner
‌
Celia Chang

Find more entities like US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo